Arkolith/Insider Trading/CMPI/Form 4

Krieg Arthur M

Chief Scientific OfficerCheckmate Pharmaceuticals, Inc. (CMPI) · full profile →Form 4 · filed May 19, 2021
Net Buying
Open-Market Buys
$174K
Open-Market Sells
$0
Net Open-Market Flow
$174K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 18, 2021Buy(P)25K$6.97$174K805K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-019922) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML